(ZEROHEDGE) – Following a flurry of data suggesting the first generation of COVID vaccines may not be as effective against certain COVID mutations, particularly a mutant strain first identified in South Africa, new "research" is suggesting patients may not even need a second dose of Pfizer's COVID-19 jab - or at least it could be delayed "in order to cover all priority groups as the first one is highly protective," according to two Canada-based researchers, who made the statement in a letter published in the New England Journal of Medicine.
Even so, new lab study has just been released Thursday suggesting that the Pfizer-BioNTech jab "stimulated lower levels of neutralizing antibodies" against the SA mutant, and that the variant could reduce the efficacy of the jab by as much as two-thirds.
All of this comes as the UN turns up the pressure on its push for a global vaccination program, via the WHO and its Covax initiative, presumably.
The post Doctors endorse delay of 2nd Pfizer shot appeared first on WND.
